Valuation: LeMaitre Vascular, Inc.

Market Cap 1.85B 1.65B 1.54B 1.4B 2.63B 176B 2.65B 18.51B 7.24B 91.03B 6.93B 6.78B 293B P/E 2026 *
28.1x
P/E 2027 * 25.4x
Enterprise Value 1.6B 1.44B 1.34B 1.21B 2.29B 153B 2.31B 16.09B 6.3B 79.17B 6.03B 5.89B 255B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.1x
Free-Float
87.26%
Yield 2026 *
1.24%
Yield 2027 * 1.39%
1 day+2.75%
1 week+2.37%
Current month+0.39%
1 month+2.65%
3 months-17.33%
6 months-28.01%
Current year+2.23%
1 week 78.31
Extreme 78.31
83.25
1 month 78.22
Extreme 78.22
83.34
Current year 78.22
Extreme 78.22
118.01
1 year 78.22
Extreme 78.22
118.01
3 years 44.27
Extreme 44.27
118.01
5 years 38.32
Extreme 38.32
118.01
10 years 18.55
Extreme 18.55
118.01
Manager TitleAgeSince
Chief Executive Officer 61 31/05/1992
Director of Finance/CFO 51 09/03/2025
Director of Finance/CFO 62 31/12/1999
Director TitleAgeSince
Director/Board Member 68 31/12/2002
Chairman 61 31/12/2003
Director/Board Member 61 23/10/2016
Date Insider Type Main position Quantity % Market Cap. Importance
03/09/26 Free

Chairperson

24 0.0001%
03/09/26 Free

Director

6 0.0000%
03/09/26 Free

Chief Operating Officer

14 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+2.75%+2.37%-2.81%+75.17% 1.85B
+0.64%-2.15%+26.24%+37.23% 243B
+0.63%-0.00%+7.83%+5.59% 155B
+0.87%+5.21%-1.86%+60.69% 150B
+2.60%+3.40%-53.83%-9.87% 61.93B
+1.38%-0.96%+18.42%+23.56% 49.12B
+1.25%+4.68%-16.06%-17.25% 48.78B
+0.46%+0.02%+23.95%+57.27% 48.08B
-0.09%+4.37%+3.41%+36.99% 47.95B
-0.38%-1.82%+28.48%+72.15% 42.62B
Average +0.57%+2.93%+3.38%+34.15% 84.79B
Weighted average by Cap. +0.25%+2.97%+7.82%+31.20%

Financials

2026 *2027 *
Net sales 277M 248M 231M 209M 395M 26.44B 397M 2.77B 1.09B 13.64B 1.04B 1.02B 43.9B 303M 271M 253M 229M 432M 28.96B 435M 3.04B 1.19B 14.94B 1.14B 1.11B 48.09B
Net income 66.71M 59.72M 55.67M 50.5M 95.24M 6.38B 95.84M 669M 262M 3.29B 251M 245M 10.59B 74.29M 66.5M 62M 56.23M 106M 7.1B 107M 745M 292M 3.66B 279M 273M 11.79B
Net Debt -240M -215M -201M -182M -343M -22.99B -346M -2.41B -944M -11.86B -903M -883M -38.18B -300M -269M -251M -227M -429M -28.72B -432M -3.01B -1.18B -14.82B -1.13B -1.1B -47.69B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change Volume
12/10/26 US$82.91 +2.75% 257,854
09/10/26 US$80.69 +1.32% 126,708
08/10/26 US$79.64 +0.42% 272,982
07/10/26 US$79.31 +0.33% 218,311
06/10/26 US$79.05 -2.40% 283,356
Trader
Investor
Global
Quality
ESG MSCI
CCC
Ratings Surperformance© - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.69USD
Average target price
107.00USD
Spread / Average Target
+32.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LeMaitre Vascular, Inc.
  1. Stock Market
  2. Stocks
  3. LMAT Stock